Mohamed GabAllah

598 total citations
22 papers, 402 citations indexed

About

Mohamed GabAllah is a scholar working on Infectious Diseases, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Mohamed GabAllah has authored 22 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Computational Theory and Mathematics and 5 papers in Organic Chemistry. Recurrent topics in Mohamed GabAllah's work include Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (5 papers) and Influenza Virus Research Studies (4 papers). Mohamed GabAllah is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (5 papers) and Influenza Virus Research Studies (4 papers). Mohamed GabAllah collaborates with scholars based in Egypt, United States and United Arab Emirates. Mohamed GabAllah's co-authors include Yassmin Moatasim, Ahmed Mostafa, Mohamed A. Ali, Ahmed Kandeil, Omnia Kutkat, Mokhtar R. Gomaa, Mahmoud Shehata, Sara H. Mahmoud, Ghazi Kayali and Ahmed A. Al‐Karmalawy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mohamed GabAllah

19 papers receiving 394 citations

Peers

Countries citing papers authored by Mohamed GabAllah

Since Specialization

Citations

This map shows the geographic impact of Mohamed GabAllah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed GabAllah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed GabAllah more than expected).

Fields of papers citing papers by Mohamed GabAllah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed GabAllah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed GabAllah. The network helps show where Mohamed GabAllah may publish in the future.

Co-authorship network of co-authors of Mohamed GabAllah

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed GabAllah. A scholar is included among the top collaborators of Mohamed GabAllah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed GabAllah. Mohamed GabAllah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023 2025 ·Viruses ·Mina Nabil Kamel, Yassmin Moatasim, Basma Emad Aboulhoda, Mokhtar R. Gomaa, Ahmed El Taweel, Omnia Kutkat, Mohamed El Sayes, Mohamed GabAllah, Hend Abd-Allah, Refaat M. Gabre, Maha AlKhazindar, Ahmed Kandeil, Pamela McKenzie, Richard J. Webby, Mohamed A. Ali, Ghazi Kayali, Rabeh El‐Shesheny	0
2	Polysaccharides from Brown Seaweeds (Padina boergesenii and Sargassum euryphyllum) as Promising Inhibitors of SARS-CoV-2: Characterization, Mechanisms, and Therapeutic Potential 2025 ·SHILAP Revista de lepidopterología ·Saly F. Gheda, (unknown), (unknown), Mohamed GabAllah, João Cotas, Leonel Pereira	2
3	Emergence of a novel reassortant highly pathogenic avian influenza clade 2.3.4.4b A(H5N2) Virus, 2024 2025 ·Emerging Microbes & Infections ·Rabeh El‐Shesheny, Mokhtar R. Gomaa, Mohamed El Sayes, Mina Nabil Kamel, Ahmed El Taweel, Omnia Kutkat, Mohamed GabAllah, (unknown), Hossam E. Emam, Yassmin Moatasim, Ahmed Kandeil, Pamela McKenzie, Richard J. Webby, Mohamed A. Ali, Ghazi Kayali	2
4	Synthesis, Molecular Docking, DFT and Pharmacophore Studies of New Naphthalene-Heterocycle Hybrids of Prospective Antiviral Activity. 2025 ·Egyptian Journal of Chemistry ·Ashraf M. Mohamed, Mohamed A. Abdelwahab, (unknown), (unknown), (unknown), Mohamed GabAllah, (unknown), Ahmed Hussein	0
5	Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies 2024 ·BMC Chemistry ·(unknown), Mazin A. A. Najm, Reham F. Barghash, Omnia Kutkat, Mohamed GabAllah, Amgad Albohy, Khaled A. M. Abouzid	1
6	Profiling the phytochemicals and anti-SARS CoV-2 activity of different Ligustrum ovalifolium Hassk aerial part extracts: An in vitro-in silico study 2024 ·Egyptian Journal of Chemistry ·(unknown), Mohamed Ayoub, Omnia Kutkat, Mohamed GabAllah, Reda Sayed Mohammed	1
7	Genetic and pathogenic potential of highly pathogenic avian influenza H5N8 viruses from live bird markets in Egypt in avian and mammalian models 2024 ·PLoS ONE ·Yassmin Moatasim, Basma Emad Aboulhoda, Mokhtar R. Gomaa, Ahmed El Taweel, Omnia Kutkat, Mina Nabil Kamel, Mohamed El Sayes, Mohamed GabAllah, (unknown), Hend Abd-Allah, Ahmed Kandeil, Mohamed A. Ali, Ghazi Kayali, Rabeh El‐Shesheny	2
8	Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023 2024 ·Emerging Microbes & Infections ·Omnia Kutkat, Mokhtar R. Gomaa, Yassmin Moatasim, Ahmed El Taweel, Mina Nabil Kamel, Mohamed El Sayes, Mohamed GabAllah, Ahmed Kandeil, Pamela McKenzie, Richard J. Webby, Ghazi Kayali, Mohamed A. Ali, Rabeh El‐Shesheny	13
9	Diverse bioactive secondary metabolites from Aspergillus terreus: antimicrobial, anticancer, and anti-SARS-CoV-2 activity studies 2024 ·Zeitschrift für Naturforschung C ·Abdelaaty Hamed, Ahmed S. Abdel‐Razek, Ahmed B. Abdelwahab, Ahmed El Taweel, Mohamed GabAllah, Norbert Sewald, Mohamed Shaaban	1
10	Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study 2022 ·Marine Drugs ·(unknown), (unknown), Omnia Kutkat, Mohamed GabAllah, Mohamed A. Ali, Mohamed E. A. El-Metwally, Ahmed M. Sayed, Usama Ramadan Abdelmohsen, Ashraf Khalil	15
11	Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies 2022 ·Scientific Reports ·Omnia Kutkat, Yassmin Moatasim, Ahmed A. Al‐Karmalawy, Hamada S. Abulkhair, Mokhtar R. Gomaa, (unknown), Noura M. Abo Shama, Mohamed GabAllah, Dina B. Mahmoud, Ghazi Kayali, Mohamed A. Ali, Ahmed Kandeil, Ahmed Mostafa	47
12	Discovery of novel thioquinazoline-N-aryl-acetamide/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: Synthesis, in vitro biological evaluation, and molecular docking studies 2022 ·Journal of Molecular Structure ·Heba T. Abdel‐Mohsen, Mohamed A. Omar, Omnia Kutkat, Ahmed M. El Kerdawy, Alaa A. Osman, Mohamed GabAllah, Ahmed Mostafa, Mohamed A. Ali, Hoda I. El Diwani	8
13	Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19 2022 ·Journal of Drug Delivery Science and Technology ·(unknown), Yassmin Moatasim, Mohamed GabAllah, Marwa Hasanein Asfour	26
14	Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates 2022 ·ChemistrySelect ·Mohamed A. Youssef, Siva S. Panda, (unknown), Mona F. Said, Ahmed El Taweel, Mohamed GabAllah, Walid Fayad, Ahmed F. Soliman, Ahmed Mostafa, (unknown), Adel S. Girgis	11
15	Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies 2022 ·Metabolites ·Howaida I. Abd‐Alla, Omnia Kutkat, (unknown), Wagdy M. Eldehna, (unknown), Magda T. Ibrahim, Yassmin Moatasim, Mohamed GabAllah, Ahmed A. Al‐Karmalawy	12
16	Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort 2021 ·PLoS Pathogens ·Mokhtar R. Gomaa, Amira S. El Refay, Mahmoud Shehata, Ahmed Kandeil, Mina Nabil Kamel, (unknown), Mohamed GabAllah, Ahmed El Taweel, Ahmed E. Kayed, Omnia Kutkat, Yassmin Moatasim, Sara H. Mahmoud, Noura M. Abo Shama, Mohamed El Sayes, Ahmed Mostafa, Rabeh El‐Shesheny, Pamela McKenzie, Richard J. Webby, Ghazi Kayali, Mohamed A. Ali	17
17	Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein 2021 ·Antibiotics ·Raha Orfali, Mostafa E. Rateb, Hossam M. Hassan, Mona Alonazi, Mokhtar R. Gomaa, (unknown), Mohamed GabAllah, Ahmed Kandeil, Shagufta Perveen, Usama Ramadan Abdelmohsen, Ahmed M. Sayed	33
18	Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2 2021 ·Molecules ·Ahmed A. Al‐Karmalawy, Mai M. Farid, Ahmed Mostafa, (unknown), Sara H. Mahmoud, Mahmoud Shehata, Noura M. Abo Shama, Mohamed GabAllah, Gomaa Mostafa‐Hedeab, Mona M. Marzouk	65
19	FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 2020 ·Pharmaceuticals ·Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, (unknown), Sara H. Mahmoud, Mohamed GabAllah, Hisham A. Abbas, Ahmed El Taweel, Ahmed E. Kayed, Mina Nabil Kamel, Mohamed El Sayes, Dina B. Mahmoud, Rabeh El‐Shesheny, Ghazi Kayali, Mohamed A. Ali	126
20	Antiviral activity of water extracts of some medicinal and nutritive plants from the Apiaceae family 2020 ·SHILAP Revista de lepidopterología ·Mohamed GabAllah, Ahmed Kandeil, (unknown), Mohamed A. Ali	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact